Genmab • GMAB
Genmab is a Copenhagen-based biotechnology company specializing in antibody therapeutics for the treatment of cancer.
Ratings
4 / 5
3 ratings in the last 12 months
5
4
3
2
1
CEO
Dr. Jan G. J. van de Winkel, PhD$18.3B
Market Cap • 25/04/20241998
(há 26 anos)
2019
(5 years ago)
NASDAQ
Listagem
Valby
1.660
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
GMABSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.